<DOC>
	<DOC>NCT00481923</DOC>
	<brief_summary>The primary objective of this study is to assess the effect of rimonabant on the energy intake (kcal/day/meal) from ad-libitum high-fat dinner (primary endpoint), pre- and post-ingestive responses, and the hedonic evaluation of food, and its effect on food choice, cravings and feelings of control. The secondary objectives are to determine the effect of rimonabant on body weight with or without hypocaloric diet and its clinical and laboratory safety.</brief_summary>
	<brief_title>Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Obese subjects with Body Mass Index ≥ 30 and &lt; 45 kg/m² The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>hypocaloric diet</keyword>
	<keyword>energy intake</keyword>
</DOC>